The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo

被引:29
作者
Murphy, Leigh C. [1 ]
Skliris, Georgios P. [1 ]
Rowan, Brian G. [2 ]
Al-Dhaheri, Mariam [2 ]
Williams, Christopher [2 ]
Penner, Carla [1 ]
Troup, Sandy [1 ]
Begic, Sanela [1 ]
Parisien, Michelle [1 ]
Watson, Peter H. [1 ]
机构
[1] Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada
[2] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA
关键词
Phosphorylation; Estrogen receptor; Breast cancer; Tissue microarrays; Immunohistochemistry; Validation; Tissue collection time; Endocrine therapy; ENDOCRINE-THERAPY; ER-ALPHA; LIGAND-BINDING; TAMOXIFEN; SURVIVAL; SERINE-118; BIOLOGY; TUMORS;
D O I
10.1016/j.jsbmb.2009.01.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor (ER)alpha activity is regulated by phosphorylation at several sites. Recently several antibodies specific for individual phosphorylated sites within ER alpha have became available. Validation and use of these antibodies suggests that several forms of phosphorylated ER alpha can be detected in multiple ER+ human breast tumor samples, thus providing relevance for investigating the regulation and function of phosphorylated ER alpha in human breast cancer. Generally, the phosphorylated ER alpha isoforms are associated with parameters that suggest that they are markers of an intact estrogen dependent signaling pathway and better clinical outcome with respect to tamoxifen therapy. Profiling of phosphorylated ER alpha may provide better biomarkers of endocrine therapy response over and above those currently available. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 27 条
[1]  
Al-Dhaheri Mariam H, 2006, Nucl Recept Signal, V4, pe007
[2]  
ATSRIKU C, 2008, MOL CELL PROTEO 1103
[3]   Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research [J].
Barnes, Rebecca O. ;
Parisien, Michelle ;
Murphy, Leigh C. ;
Watson, Peter H. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (12) :3344-3350
[4]   Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen [J].
Bergqvist, Jenny ;
Elmberger, Goran ;
Ohd, John ;
Linderholm, Barbro ;
Bjohle, Judith ;
Hellborg, Henrik ;
Nordgren, Hans ;
Borg, Anna-Lena ;
Skoog, Lambert ;
Bergh, Jonas .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1104-1112
[5]   Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera [J].
Chen, DS ;
Washbrook, E ;
Sarwar, N ;
Bates, GJ ;
Pace, PE ;
Thirunuvakkarasu, V ;
Taylor, J ;
Epstein, RJ ;
Fuller-Pace, FV ;
Egly, JM ;
Coombes, RC ;
Ali, S .
ONCOGENE, 2002, 21 (32) :4921-4931
[6]   Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience [J].
Dowsett, M ;
Johnston, S ;
Martin, LA ;
Salter, J ;
Hills, M ;
Detre, S ;
Gutierrez, MC ;
Mohsin, SK ;
Shout, J ;
Allred, DC ;
Osborne, CK ;
Smith, I .
ENDOCRINE-RELATED CANCER, 2005, 12 :S113-S117
[7]   Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer [J].
Gee, JM ;
Robertson, JF ;
Gutteridge, E ;
Ellis, IO ;
Pinder, SE ;
Rubini, M ;
Nicholson, RI .
ENDOCRINE-RELATED CANCER, 2005, 12 :S99-S111
[8]   Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J].
Harvey, JM ;
Clark, GM ;
Osborne, CK ;
Allred, DC .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1474-1481
[9]  
HOLM C, 2008, J PATHOL 0923
[10]   Phosphorylation of estrogen receptor-α at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients [J].
Jiang, Jie ;
Sarwar, Naveed ;
Peston, David ;
Kulinskaya, Elena ;
Shousha, Sami ;
Coombes, R. Charles ;
Ali, Simak .
CLINICAL CANCER RESEARCH, 2007, 13 (19) :5769-5776